Condition: Vascular Surgical Procedure · Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust
The team is investigating whether N-terminal pro B-type natriuretic peptide (NT-proBNP) and other cardiac markers are useful for predicting outcomes for patients undergoing vascular surgery. By measuring NT-proBNP before and after surgery, the investigators may be able to determine which patients are at risk of an adverse outcome, such as a heart attack or death.
This description comes directly from the study's public registry record.
Emma Miler, MSc BSc Hons · +44(0)1603-286-932 · emma.miler@nnuh.nhs.net
Allison Chipchase, Dr · +44(0)1603-286-929 · allison.chipchase@nnuh.nhs.net
Always discuss trial participation with your own doctor first.
| Norfolk & Norwich University Hospitals NHS Foundation Trust | Norwich, Norfolk, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04014647